These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36298490)

  • 1. Trial Evaluation of Protection and Immunogenicity of Piscine Bivalent Streptococcal Vaccine: From the Lab to the Farms.
    Kannika K; Sirisuay S; Kondo H; Hirono I; Areechon N; Unajak S
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-protective efficiency of feed-based whole-cell inactivated bivalent vaccine against Streptococcus and Aeromonas infections in red hybrid tilapia (Oreochromis niloticus × Oreochromis mossambicus).
    Monir MS; Yusoff MSM; Zulperi ZM; Hassim HA; Zamri-Saad M; Amal MNA; Salleh A; Mohamad A; Yie LJ; Ina-Salwany MY
    Fish Shellfish Immunol; 2021 Jun; 113():162-175. PubMed ID: 33857622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia,
    Amrullah A; Wahidah W; Ardiansyah A; Indrayani I
    F1000Res; 2021; 10():966. PubMed ID: 37767359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Protection and Humoral Immune Response in Nile Tilapia (
    Queiróz GA; Silva TMFE; Leal CAG
    Animals (Basel); 2024 Jun; 14(12):. PubMed ID: 38929363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).
    Monir MS; Yusoff SBM; Zulperi ZBM; Hassim HBA; Mohamad A; Ngoo MSBMH; Ina-Salwany MY
    BMC Vet Res; 2020 Jul; 16(1):226. PubMed ID: 32615969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.
    Delphino MKVC; Barone RSC; Leal CAG; Figueiredo HCP; Gardner IA; Gonçalves VSP
    Prev Vet Med; 2019 Jan; 162():131-135. PubMed ID: 30621892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
    Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
    Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity in Oreochromis niloticus vaccinated with sonicated antigens against streptococcosis.
    Marcusso PF; da Silva Claudiano G; Yunis-Aguinaga J; de Almeida Marinho-Neto F; Eto SF; Fernandes DC; Rosolem MC; Salvador R; Engracia de Moraes JR; Ruas de Moraes F
    Fish Shellfish Immunol; 2021 Aug; 115():134-141. PubMed ID: 34098067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Efficient Piscine Oral Nano-Vaccine Delivery System: Modified Halloysite Nanotubes (HNTs) Preventing Streptococcosis Disease in Tilapia (
    Pumchan A; Sae-Ueng U; Prasittichai C; Sirisuay S; Areechon N; Unajak S
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Efficacy of a Feed-Based Bivalent Vaccine against Streptococcosis and Motile Aeromonad Septicemia in Red Hybrid Tilapia (
    Mohd Ali NS; Saad MZ; Azmai MNA; Salleh A; Zulperi ZM; Manchanayake T; Zahaludin MAD; Basri L; Mohamad A; Md Yasin IS
    Animals (Basel); 2023 Apr; 13(8):. PubMed ID: 37106909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
    Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an inactivated whole-cell injection vaccine for nile tilapia, Oreochromis niloticus (L), against multiple isolates of Francisella noatunensis subsp. orientalis from diverse geographical regions.
    Shahin K; Shinn AP; Metselaar M; Ramirez-Paredes JG; Monaghan SJ; Thompson KD; Hoare R; Adams A
    Fish Shellfish Immunol; 2019 Jun; 89():217-227. PubMed ID: 30951851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
    Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus).
    Pridgeon JW; Klesius PH
    Vaccine; 2011 Aug; 29(35):5986-93. PubMed ID: 21708205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular serotyping, virulence gene profiling and pathogenicity of Streptococcus agalactiae isolated from tilapia farms in Thailand by multiplex PCR.
    Kannika K; Pisuttharachai D; Srisapoome P; Wongtavatchai J; Kondo H; Hirono I; Unajak S; Areechon N
    J Appl Microbiol; 2017 Jun; 122(6):1497-1507. PubMed ID: 28295891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and mucosal antibody response of freshwater cultured Asian seabass (Lates calcarifer) to monovalent and bivalent vaccines against Streptococcus agalactiae and Streptococcus iniae.
    Thu Lan NG; Salin KR; Longyant S; Senapin S; Dong HT
    Fish Shellfish Immunol; 2021 Jan; 108():7-13. PubMed ID: 33217566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
    Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
    Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Vaccination Strategies and Antigen Delivery Systems for Streptococcus agalactiae Vaccines in Nile Tilapia (Oreochromis niloticus).
    Munang'andu HM; Paul J; Evensen Ø
    Vaccines (Basel); 2016 Dec; 4(4):. PubMed ID: 27983591
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of Streptococcus agalactiae vaccines for tilapia.
    Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
    Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.